ELA026 in sHLH
Phase Ib Study of ELA026, an Anti-SIRP-α/β/γ mAb, in Patients With Secondary Hemophagocyctic Lymphohistiocytosis

Released: December 13, 2024

Expiration: December 12, 2025

Activity

Progress
1
Course Completed